Screener
IHE vs IYH
iShares U.S. Pharmaceuticals ETF vs iShares U.S. Healthcare ETF
Key differences
- Over the last 3 years, IHE has delivered higher annualized returns.
- IYH has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| IHE | IYH | |
|---|---|---|
| Annual cost (TER) | 0.38% | 0.38% |
| Fund size (AUM) | $946M | $2.8B |
| Since | 2006 | 2000 |
| Dividend yield | 1.70% | 1.31% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +46.2% | +16.1% |
| CAGR 3Y | +18.0% | +5.8% |
| CAGR 5Y | +10.1% | +4.8% |
| Sharpe 3Y | 0.87 | 0.22 |
| Volatility 1Y | 16.91% | 14.63% |
| Max drawdown | -29.59% | -28.40% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to IHE and IYH
Explore further